The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1b/2 study of batiraxcept (AVB-S6-500) in combination with cabozantinib in patients with advanced or metastatic clear cell renal cell carcinoma (ccRCC).
 
Neil J. Shah
Consulting or Advisory Role - Merck Sharp & Dohme Corp.
Research Funding - Aravive (Inst)
Travel, Accommodations, Expenses - Merck
 
Matthew T Campbell
Honoraria - Astellas Pharma; AstraZeneca; Axdev; Curio Science; Exelixis; Seagen
Consulting or Advisory Role - EMD Serono; Exelixis; Pfizer; Seagen
Research Funding - Apricity Health (Inst); Aravive (Inst); Exelixis (Inst); Janssen Oncology (Inst); Pfizer/EMD Serono (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AVEO; Seagen
Other Relationship - Curio Science
 
Shifeng S. Mao
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Cardinal Health; Exelixis; Pfizer; Sanofi; Seattle Genetics/Astellas
Speakers' Bureau - Bristol-Myers Squibb
 
Moshe Chaim Ornstein
Consulting or Advisory Role - AVEO; Bristol Myers Squibb Foundation; Eisai; Exelixis; Merck; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Merck
Research Funding - Aravive (Inst); Astellas Medivation (Inst); AstraZeneca/MedImmune (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Pfizer (Inst); Surface Oncology (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Eisai; Exelixis; Merck; Pfizer
 
Naomi B. Haas
Consulting or Advisory Role - AVEO; Calithera Biosciences; Eisai; Exelixis; Merck Sharp & Dohme; Pfizer; Roche/Genentech
Expert Testimony - Lilly (I)
 
Xin Gao
Consulting or Advisory Role - Bayer; Flare Therapeutics; Guardant Health; Myovant Sciences; PureTech; Silverback Therapeutics
Research Funding - Aprea Therapeutics (Inst); Aravive (Inst); Arvinas (Inst); Exelixis (Inst); Harpoon therapeutics (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Poseida therapeutics (Inst); Regeneron (Inst); Silverback Therapeutics (Inst); Takeda (Inst); TopAlliance BioSciences Inc (Inst)
 
Hans J. Hammers
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - ARMO BioSciences; Bayer; Bristol-Myers Squibb; Corvus Pharmaceuticals; exelixis; Lilly; Merck; Novartis; Pfizer; Surface Oncology
Research Funding - aravive (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Surface Oncology (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; Merck; Novartis; Pfizer
 
Holavanahalli Keshava-Prasad
No Relationships to Disclose
 
Hongxia Yan
Employment - Aravive
Stock and Other Ownership Interests - Aravive
 
Vanessa Esquibel
Employment - Aravive
Stock and Other Ownership Interests - Aravive
 
Robert B. Geller
Employment - Aravive
Leadership - Aravive
 
Katy Beckermann
Consulting or Advisory Role - Alpine Immune Sciences; Aravive; AstraZeneca; AVEO; Bristol-Myers Squibb; Exelixis; Merck; Sanofi; Seagen
Research Funding - Aravive (Inst); ArsenalBio (Inst); Bristol-Myers Squibb; Merck Sharp & Dohme; Pionyr (Inst)